Hilde W. van Kouswijk

Ms. Hilde W. van Kouswijk

Orthopaedics, Leiden University Medical Center, Leiden, The Netherlands
+2
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2021 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
HBHugo F. G. Brouwers
Hugo F. G. Brouwers
AVA. J. de Vries
A. J. de Vries
MZM. van Zuilen
M. van Zuilen
Hilde W. van KouswijkHilde W. van Kouswijk
Hilde W. van Kouswijk
RBR. W. Brouwer
R. W. Brouwer

23 March 2023 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
Hilde W. van KouswijkHilde W. van Kouswijk
Hilde W. van Kouswijk
HKH. G. van Keeken
H. G. van Keeken
JPJoris Jan Willem Ploegmakers
Joris Jan Willem Ploegmakers
GSGesine H. Seeber
Gesine H. Seeber
IAI. van Den Akker-Scheek
I. van Den Akker-Scheek
Background: An increasing number of patients are surviving sarcoma after lower limb-salvage surgery (LSS) and are left with functional limitations. This systematic review aimed to determine the therapeutic validity and effectiveness of exercise interventions after lower limb-salvage surgery (LSS) for sarcoma. Methods: A systematic review was conducted using formal narrative synthesis of intervention studies (with and without control group) identified through PubMed, Embase, Cochrane Library, CINAHL, and PEDro databases. Studies were included if participants were treated with LSS for unilateral lower limb sarcoma and followed an exercise intervention using active exercise, physical training, or rehabilitation before and/or after surgery. This review’s outcome measures were interventions’ therapeutic validity, assessed using the CONTENT scale (0 to 9); methodological quality, identified using the Downs & Black checklist (0 to 28); interventions’ effectiveness, assessed based on differences in outcome measures between intervention and control groups; and certainty of evidence, classified according to the GRADE approach. Results: Seven studies involving 214 participants were included. None of the included interventions were therapeutically valid (median 5, range 1–5). All but one study were of at least fair methodological quality (median 18, range 14–21). There was very low-quality evidence that exercise interventions resulted in increased knee range of motion (MD 10–15°) or compliance (MD 30%), and reduced functionality scores (MD -5%) compared to usual care. Conclusions: We found overall low therapeutic validity of interventions, performed in overall low-quality studies. Combined with the very low certainty of evidence, the results prevent drawing valid conclusions on the interventions’ effectiveness. Future studies should aim for uniformity among their methodological approaches and outcome measures, using the CONTENT scale as a template to avert insufficient reporting. Trial registration: PROSPERO CRD42021244635.

13 February 2025 in Journal of Bone and Joint Surgery
Verified
Journal Article
Open access
Hilde W. van KouswijkHilde W. van Kouswijk
Hilde W. van Kouswijk
MBM.P.A. Bus
M.P.A. Bus
MGM.G.J. Gademan
M.G.J. Gademan
RNR.G.H.H. Nelissen
R.G.H.H. Nelissen
Pieter Bas de WittePieter Bas de Witte
Pieter Bas de Witte
Background: Total hip arthroplasty (THA) is rarely performed in pediatric patients and can be challenging in children because of smaller-sized joints, pathomorphological changes around the hip, residual growth, and higher physical demands. Literature on THA outcomes in this unique population is scarce. We aimed to describe characteristics of pediatric patients who underwent THA, 5- and 10-year implant survival, risk factors for revision, and results of patient-reported outcome measures (PROMs) in a large national cohort. Methods: Primary THAs (from 2007 through 2022) in pediatric patients (11 to 18 years of age) for non-oncological indications were extracted from the Dutch Arthroplasty Register (LROI). Implant survival was assessed using Kaplan-Meier survival analyses. Functional, quality-of-life, and pain-related PROM scores were described preoperatively and at 3 and 12 months postoperatively and compared using paired t tests. Results: We included 283 THAs (161 [57%] in female patients) performed in 253 patients. The mean age at surgery (and standard deviation) was 16 ± 1.6 years. The most common indications were osteonecrosis (90 [32%] of the THA procedures), dysplasia (82 [29%]), and osteoarthritis (54 [19%]). The median follow-up was 7 years (range, 2 to 16 years). Fourteen (6% of 234) THAs were revised. The 5- and 10-year cumulative survival rates were 95% (95% confidence interval [CI], 91% to 97%) and 91% (95% CI, 84% to 95%), respectively. There was an insufficient number of events to allow for statistical analyses of potential risk factors for revision. All PROMs had improved significantly at 12 months postoperatively versus preoperatively (p < 0.001). Conclusions: This study, the largest to date on THA in children (≤18 years of age), showed good short- and mid-term THA survival, approaching that among adults. Combined with the positive PROM results, THA appears to be an effective and satisfactory intervention in cases of debilitating pediatric hip disease. Further studies should focus on long-term survival and risk factors for implant failure. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

16 May 2025 in Children
Verified
Journal Article
Open access
PDF file
Hilde W. van KouswijkHilde W. van Kouswijk
Hilde W. van Kouswijk
HYHizbillah Yazid
Hizbillah Yazid
JSJan Schoones
Jan Schoones
AWAdhiambo M. Witlox
Adhiambo M. Witlox
RNRob G. H. H. Nelissen
Rob G. H. H. Nelissen
Pieter Bas de WittePieter Bas de Witte
Pieter Bas de Witte
Introduction: Paediatric hip disorders present unique challenges for artificial intelligence (AI)-aided assessments of medical imaging due to disease-related and age-dependent changes in hip morphology. This scoping review aimed to describe current and emerging applications of AI in medical imaging for paediatric hip disorders. Methods: A descriptive synthesis of articles identified through PubMed, Embase, Cochrane Library, Web of Science, Emcare, and Academic Search Premier databases was performed including articles published up until June 2024. Original research articles’ titles and abstracts were screened, followed by full-text screening. Two reviewers independently conducted article screening and data extraction (i.e., data on the article and the model and its performance). Results: Out of 871 unique articles, 40 were included. The first article was dated from 2017, with annual publication rates increasing thereafter. Research contributions were primarily from China (17 [43%]) and Canada (10 [25%]). Articles mainly focused on developing novel AI models (19 [47.5%]), applied to ultrasound images or radiographs of developmental dysplasia of the hip (DDH; 37 [93%]). The three remaining articles addressed Legg–Calvé–Perthes disease, neuromuscular hip dysplasia in cerebral palsy, or hip arthritis/osteomyelitis. External validation was performed in eight articles (20%). Models were mainly applied to the diagnosis/grading of the disorder (22 [55%]), or on screening/detection (17 [42.5%]). AI models were 17 to 124 times faster (median 30) in performing a specific task than experienced human assessors, with an accuracy of 86–100%. Conclusions: Research interest in AI applied to medical imaging of paediatric hip disorders has expanded significantly since 2017, though the scope remains restricted to developing novel models for DDH imaging. Future studies should focus on (1) the external validation of existing models, (2) implementation into clinical practice, addressing the current lack of implementation efforts, and (3) paediatric hip disorders other than DDH.

12 August 2024 in Disability and Rehabilitation
Verified
Journal Article
Open access
Hilde W. van KouswijkHilde W. van Kouswijk
Hilde W. van Kouswijk
JVJ. Vrijsen
J. Vrijsen
GSGesine H. Seeber
Gesine H. Seeber
EPErja Portegijs
Erja Portegijs
IAI. van Den Akker-Scheek
I. van Den Akker-Scheek
Survival rates of lower extremity musculoskeletal tumours (LEMTs) have been increasing. However, patients continue to experience functional limitations after LEMT followed by limb-salvage surgery (LSS). This study aimed to identify factors influencing functional recovery after LSS for LEMT. A qualitative study was conducted using semi-structured interviews with a purposive sample of adult patients who underwent LSS for LEMT (n=7) and healthcare professionals (HCPs) with expertise in orthopaedic oncology (n=7). Recruitment continued until data saturation. A combination of deductive and inductive qualitative content analysis was performed to analyse the transcribed data, producing subthemes under the main International Classification of Functioning, disability and health (ICF)-model domains. Four themes were described: (1) bodily functions and structures, (2) activities and participation, (3) environmental factors, and (4) expectations. Physical aspects such as larger resection size and complications negatively affected recovery. The importance of communication strategies of tertiary HCPs and the unfamiliarity of the primary physical therapists with the disease, its surgical treatment, and related consequences were emphasised by both the interviewed patients and HCPs. Functional recovery after LSS for LEMT is a multifactorial process. To improve patient care, improving (intercollegiate) communication strategies on treatment details and expectations about functional outcomes is warranted.Implications for rehabilitationHealthcare professionals should be aware some patients experience limited functional recovery after limb-salvage surgery (LSS) for lower extremity musculoskeletal tumours.Healthcare professionals should use multiple communication strategies to bridge the gap between the information provided and what the patient recalls.Knowledge exchange and communication between primary and tertiary care should be more extensive.Multidisciplinary consultations and/or case managers are needed to address all aspects of the individual's functional recovery after LSS.

3 September 2025 in Children
Verified
Journal Article
Open access
PDF file
FMFrederike E.C.M. Mulder
Frederike E.C.M. Mulder
Hilde W. van KouswijkHilde W. van Kouswijk
Hilde W. van Kouswijk
AWAdhiambo M. Witlox
Adhiambo M. Witlox
NMNina Maria Cornelia Mathijssen
Nina Maria Cornelia Mathijssen
Pieter Bas de WittePieter Bas de Witte
Pieter Bas de Witte
Background/Objectives: Developmental dysplasia of the hip (DDH) is one of the most common pediatric orthopedic disorders and warrants timely diagnosis and treatment to prevent long-term disability. This review identified, summarized, and assessed the quality of current European national guidelines for DDH screening and treatment. Methods: Guidelines were identified by contacting the national orthopedic societies from 46 European countries and retrieving the guidelines from a recent systematic review. Two researchers independently extracted data and assessed guideline quality using the AGREE II checklist. Interrater agreement was assessed using Cohen’s κ. Results: Nine European national DDH guidelines were identified, of which four were published in peer-reviewed scientific journals. All guidelines advised clinical examination and imaging as part of the DDH screening program, though screening approach and timing varied considerably. Four guidelines included treatment recommendations. The type of treatment (abduction treatment vs. active monitoring) and duration of long-term follow-up showed great variation. Guideline quality ranged from 16 to 92% (Cohen’s κ = 0.62), with two out of nine guidelines rated “good quality” (>70%). Conclusions: European national DDH guidelines appear scarce and of varying quality and content. A coordinated European initiative is warranted to urge countries to develop evidence-based DDH guidelines using validated tools and to publish these guidelines in peer-reviewed journals, thereby advancing equal diagnosis and treatment for children with DDH.